Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatisis (NASH) are emerging as the most prevalent causes of liver disease in Western countries. There are various methods used to evaluate fat content as well as other characteristics of the liver. Medical imaging provides a non-invasive approach to quantify tissue characteristics of the liver while reducing errors in diagnosis and disease staging.
Download our white paper to discover:
- The causes of NAFLD and NASH
- Symptoms and disease progression
- Diagnosis, treatment and evaluation of liver fat
- How to use Ultrasound, CT imaging, MR spectroscopy and MR imaging techniques for assessing liver fat content
As a leader of hepatic fat imaging and quantification, our team will work with you to determine the imaging modality, acquisition protocol and analysis method that will best serve your study.